Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid plus stereotactic radiotherapy for vertebral metastases
2019-001209-26Phase 3Active
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of zoledronic acid in spinal metastases and pain (2 arms), sponsored by Institut Cancérologique de l'Ouest. Started May 2019; status: active.
02
Drugs
zoledronic acid
03
Conditions
spinal metastasespain
Beyond the preview
Go deeper on 2019-001209-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001209-26.